Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorothy McCoy

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
P & T : a Peer-Reviewed Journal for Formulary Management|March 3, 2017
An Evaluation of Selected Indications and Appropriateness of Ampicillin/Sulbactam, an Unrestricted Antimicrobial, at a Single CenterDorothy McCoy, Rani Sebti, Arpi G Kuyumjian
Pharmacotherapy|October 28, 2009
Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic conceptsDorothy McCoy, Daryl D Depestel, Peggy L Carver
The Journal of Antimicrobial Chemotherapy|June 24, 2011
Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?Esther A King, Dorothy McCoy, Samit Desai, et al.
Antimicrobial Agents and Chemotherapy|May 10, 2017
Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae InfectionsMadeline King, Emily Heil, Safia Kuriakose, et al.
Microbiology Spectrum|February 1, 2024
Respiratory virus coinfections during the COVID-19 pandemic: epidemiologic analysis and clinical outcomes from the Phase 2/3 molnupiravir trial (MOVe-OUT)Matthew G Johnson, Julie M Strizki, Erin Jensen, et al.
Open Forum Infectious Diseases|November 30, 2018
Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Infections: A Multicenter StudyJason C Gallagher, Michael J Satlin, Abdulrahman Elabor, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
P & T : a Peer-Reviewed Journal for Formulary Management|March 3, 2017
An Evaluation of Selected Indications and Appropriateness of Ampicillin/Sulbactam, an Unrestricted Antimicrobial, at a Single CenterDorothy McCoy, Rani Sebti, Arpi G Kuyumjian
Pharmacotherapy|October 28, 2009
Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic conceptsDorothy McCoy, Daryl D Depestel, Peggy L Carver
The Journal of Antimicrobial Chemotherapy|June 24, 2011
Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?Esther A King, Dorothy McCoy, Samit Desai, et al.
Antimicrobial Agents and Chemotherapy|May 10, 2017
Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae InfectionsMadeline King, Emily Heil, Safia Kuriakose, et al.
Microbiology Spectrum|February 1, 2024
Respiratory virus coinfections during the COVID-19 pandemic: epidemiologic analysis and clinical outcomes from the Phase 2/3 molnupiravir trial (MOVe-OUT)Matthew G Johnson, Julie M Strizki, Erin Jensen, et al.
Open Forum Infectious Diseases|November 30, 2018
Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Infections: A Multicenter StudyJason C Gallagher, Michael J Satlin, Abdulrahman Elabor, et al.
Pageof 1